Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (411-420 of 527) with videos related to

Pageof 53
Sort By:
Plos One|February 4, 2021
Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antiviralsChuan-Pin Lin, Po-Cheng Liang, Ching-I Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2024
Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside AnaloguesTyng-Yuan Jang, Yu-Ting Zeng, Po-Cheng Liang, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver DiseaseJee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.
The Kaohsiung Journal of Medical Sciences|November 10, 2023
Air pollution associate with advanced hepatic fibrosis among patients with chronic liver diseaseTyng-Yuan Jang, Chi-Chang Ho, Po-Cheng Liang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 9, 2017
Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohortTa-Wei Liu, Pei-Chien Tsai, Ching-I Huang, et al.
Gut|April 22, 2014
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trialChen-Hua Liu, Chun-Jen Liu, Chung-Feng Huang, et al.
Hepatology International|September 25, 2023
Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort studyChin-I Shih, Kuan-Ta Wu, Meng-Hsuan Hsieh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 23, 2021
On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patientsChung-Feng Huang, Tyng-Yuan Jang, Dae Won Jun, et al.
The Kaohsiung Journal of Medical Sciences|November 9, 2023
Patient-centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in TaiwanChung-Feng Huang, Tyng-Yuan Jang, Shun-Chieh Yu, et al.
Journal of Viral Hepatitis|May 18, 2026
Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry StudyYusuf Yilmaz, Ming-Lung Yu, Khalid Alswat, et al.
Pageof 53

Showing results (411-420 of 527) with videos related to

Sort By:
Pageof 53
Plos One|February 4, 2021
Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antiviralsChuan-Pin Lin, Po-Cheng Liang, Ching-I Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2024
Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside AnaloguesTyng-Yuan Jang, Yu-Ting Zeng, Po-Cheng Liang, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver DiseaseJee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.
The Kaohsiung Journal of Medical Sciences|November 10, 2023
Air pollution associate with advanced hepatic fibrosis among patients with chronic liver diseaseTyng-Yuan Jang, Chi-Chang Ho, Po-Cheng Liang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 9, 2017
Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohortTa-Wei Liu, Pei-Chien Tsai, Ching-I Huang, et al.
Gut|April 22, 2014
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trialChen-Hua Liu, Chun-Jen Liu, Chung-Feng Huang, et al.
Hepatology International|September 25, 2023
Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort studyChin-I Shih, Kuan-Ta Wu, Meng-Hsuan Hsieh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 23, 2021
On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patientsChung-Feng Huang, Tyng-Yuan Jang, Dae Won Jun, et al.
The Kaohsiung Journal of Medical Sciences|November 9, 2023
Patient-centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in TaiwanChung-Feng Huang, Tyng-Yuan Jang, Shun-Chieh Yu, et al.
Journal of Viral Hepatitis|May 18, 2026
Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry StudyYusuf Yilmaz, Ming-Lung Yu, Khalid Alswat, et al.
Pageof 53